← All guides

Guides

Parent Briefing: Skincubator First U.S. Uses and Papablic Bedside Sleeper Recall — What to Check Today (October 15, 2026)

Parenting · October 16, 2026 · 2 min read · By AnbuBaby

# Parent Briefing: Skincubator First U.S. Uses and Papablic Bedside Sleeper Recall — What to Check Today

**October 15, 2026**

Two items for parents this week: a promising NICU development and an immediate product-safety action.

**Skincubator — wearable incubator for longer skin-to-skin**

Children’s Memorial Hermann Hospital in Houston is the first U.S. center using the Skincubator in a clinical trial. A Houston father became the first dad in Texas to hold his 26-week twins skin-to-skin with the device while the infants remained on respiratory support and lines. The wearable unit maintains warmth and humidity on a parent’s chest and organizes tubing so transfers take under three minutes. Early studies showed smaller temperature drops and less hypothermia time than conventional kangaroo care. The device has FDA Breakthrough designation; larger trials are ongoing. If your baby is in a participating NICU, ask the team about eligibility. Traditional skin-to-skin remains valuable wherever it can be done safely.

**Papablic bedside sleepers recalled**

CPSC announced today a recall of about 248 Papablic convertible bedside sleepers with play-yard extensions (model PAPA03001AI). The mattress can shift, creating an entrapment/suffocation gap, and the latching mechanism can fail, causing collapse and fall or entrapment risk. Sold on Amazon and papablic.com April 2025–July 2026 for about $190. Gray exterior, stars-and-moon interior. No injuries reported. Stop use immediately. Contact [email protected] or the Papablic recall page for refund after proof of destruction. Model number is on a label under the mattress pad.

**Also on the radar**

- US measles cases remain elevated (over 4,000 this year). Confirm household MMR status and ask your pediatrician about timing for infants.
- Respiratory season continues. Clinic questions about maternal vaccines, nirsevimab for eligible infants, and flu shots are timely.

Check your sleep products against CPSC.gov/Recalls. For NICU families, the practical step is a conversation with your care team about when and how skin-to-skin can happen.

*Not medical or legal advice. Follow your clinician’s guidance and official recall instructions.*

Comments (0)

No comments yet.

Sign in to comment.

Any length 2 3 4 5 6 7 8 9 10 11 12